Baidu
map

JCEM: 研究显示糖尿病合并慢性胰腺炎并发症风险加倍

2020-03-13 国际糖尿病 网络

糖尿病是以胰岛素抵抗和分泌不足为特征的进行性代谢疾病,慢性胰腺炎是胰腺逐渐纤维化进而胰腺内分泌及外分泌功能逐渐丧失的进展性炎症疾病。当二者合并存在,会对健康带来怎样的影响?近日,发表于《临床内分泌与代

糖尿病是以胰岛素抵抗和分泌不足为特征的进行性代谢疾病,慢性胰腺炎是胰腺逐渐纤维化进而胰腺内分泌及外分泌功能逐渐丧失的进展性炎症疾病。当二者合并存在,会对健康带来怎样的影响?近日,发表于《临床内分泌与代谢杂志》的一项基于中国台湾人群的研究结果显示,糖尿病合并慢性胰腺炎可进一步增加严重并发症的风险,如糖尿病酮症酸中毒(DKA)、高血糖高渗状态和低血糖。

这项队列研究以1999~2010年506例新诊断慢性胰腺炎(CP)且合并糖尿病成人患者为研究队列,同时以5060例年龄和性别相匹配且同期没有慢性胰腺炎的糖尿病患者作为对照队列。主要观察指标为DKA、高血糖高渗状态、低血糖事件发生率和死亡率。


糖尿病合并慢性胰腺炎并发症风险更高
研究队列(糖尿病合并慢性胰腺炎)中以男性(88.9%)为主,以中青年居多(<45岁:60.08%,45~64岁:32.02%,≥65岁:7.90%)。与对照队列相比,研究队列中受试者合并症更多,包括CKD、肝病、酒精中毒、胆石症、尿路感染和肺炎;糖尿病相关并发症也更多(aDCSI评分更高)(P=0.026)。

研究队列中,DKA1年、5年和10年累积发生率分别为2.2%、11.1%和14.4%,对照队列中分别为0.3%、1.1%和1.8%,研究队列中受试者发生DKA风险高出对照队列9.5倍(95%CI,6.51~13.91,P<0.0001),见图1。


图1. 糖尿病合并慢性胰腺炎患者DKA发生率高于单纯糖尿病患者

研究队列中,高血糖高渗状态1年、5年和10年累积发生率分别为1.2%、5.3%和7.1%,对照队列中分别为0.2%、0.7%和1.1%,研究队列中受试者发生高血糖高渗状态风险高出对照队列4.96倍(95%CI,2.85-8.62,P<0.0001),见图2。


图2 糖尿病合并慢性胰腺炎高血糖高渗状态发生率高于单纯糖尿病患者

研究队列中,低血糖1年、5年和10年累积发生率分别为2.4%、10.5%和21.1%,对照队列中分别为0.7%、3.1%和5.6%,研究队列中受试者发生低血糖风险高出对照队列3.02倍(95%CI,2.23-4.08,P<0.0001)。见图3。


图3 糖尿病合并慢性胰腺炎患者低血糖发生率高于单纯糖尿病患者


糖尿病合并慢性胰腺炎全因死亡率升高2.43倍
研究队列中受试者全因死亡率为23.88‰,对照队列中为6.87‰。在对其他共病进行调整后,研究队列中受试者的死亡风险高出对照队列的2.43倍(95%CI,1.82-3.27,P<0.0001)。见图4。


图4 糖尿病合并慢性胰腺炎患者全因死亡率高于单纯糖尿病患者

此项研究结果显示,糖尿病合并慢性胰腺炎发生急性并发症风险显著增加,包括DKA、高血糖高渗状态、低血糖和死亡。目前已分析其间的相关性,还需进一步研究以明确因果关系。同时,需要更加密切地关注这一人群的血糖管理和降糖药物的使用情况。

中国台湾台南智美医疗中心肾内科副教授Chih-Chiang Chien表示:“糖尿病合并慢性胰腺炎患者发生DKA、高血糖高渗状态和低血糖的风险分别高于单纯糖尿病患者的9.5倍、5倍和3倍。建议糖尿病患者避免饮酒,有胆道疾病者尽早治疗,定期监测血脂水平,以避免慢性胰腺炎的发生。对于合并慢性胰腺炎的糖尿病患者,应预防高血糖危象和低血糖。“


原始出处:
LinCH,etal.Effect of Chronic Pancreatitis on Complications and Mortality in DM Patients: A 10-year Nationwide Cohort Study. JClinEndocrinolMetab.2020;doi:10.1210/clinem/dgaa035.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2021-10-19 ms9000000682899257

    受教了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2020-07-12 achengzhao
  3. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2021-02-26 smallant2015
  4. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2020-04-04 丁鹏鹏
  5. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2020-03-14 MYcat124

    糖尿病和胰腺癌也有相关性

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2020-03-14 misszhang

    谢谢MedSci提供最新的资讯

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1061754, encodeId=ba471061e540f, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Tue Oct 19 09:58:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063314, encodeId=91bf20633142b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 12 16:29:18 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777932, encodeId=2b391e77932c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Feb 26 14:29:18 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758219, encodeId=31ef1e58219b4, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 04 19:29:18 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380451, encodeId=2c89380451e9, content=糖尿病和胰腺癌也有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 14 07:03:49 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043003, encodeId=26d41043003af, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Mar 14 01:29:18 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380442, encodeId=573b380442b3, content=學習了,很有用,不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 14 00:23:56 CST 2020, time=2020-03-14, status=1, ipAttribution=)]
    2020-03-14 飛歌

    學習了,很有用,不錯

    0

相关资讯

每天刷牙3次可防糖尿病! 韩国研究:年轻人有牙周病,更易患糖尿病

近期,韩国一项研究称,多刷牙可能预防糖尿病功效。研究者发现,牙周病和牙齿缺失≥15颗者,糖尿病风险分别增加了9%和21%。而每天刷牙≥3次可降低8%的糖尿病风险。进一步分析显示,刷牙对≤51岁者与≥52岁的影响有所不同。对于≤51岁者,与每天刷牙≤1次的人相比,刷牙2次糖尿病风险降低了10%,刷牙3次则降低了14%。在≥52岁者,每天刷牙2次没有预防作用,每天刷牙3次糖尿病风险降低7%。牙周病对年

Cell:肠道菌群代谢物恢复胰岛功能

微生物影响我们健康的一个基本途径是通过代谢产物的产生。肠道中的细菌数量众多,会产生大量代谢产物,这些代谢产物可以影响从免疫系统到心理健康在内的所有事物。

JAMA Surg:减肥手术对II型糖尿病患者临床改善作用

Roux-en-Y胃旁路术在改善肥胖糖尿病患者症状方面的效果优于袖状胃切除术

JACC:liraglutide对2型糖尿病患者心血管的影响

本研究的目的旨在评估胰高血糖素样肽-1受体激动剂liraglutide对LEADER临床试验中患者的心血管事件发生和死亡率的影响。

Nature Metabolism: T2D影响肥胖者的菌群分布

来自加拿大拉瓦尔大学魁北克心肺研究所(IUCPQ)和麦克马斯特大学的研究人员在《Nature Metabolism》杂志上发表的一项研究指出,与非糖尿病患者相比,糖尿病患者的血液、肝脏和某些腹部脂肪沉

ANN:老人白天老打瞌睡不是好事儿!

对于很多老年人,眯着眼睛躺在躺椅上一睡半天好似很惬意。 但近日美国斯坦福大学进行的一项研究发现,白日嗜睡不是什么好事儿,会增加糖尿病、癌症以及高血压等疾病风险。

Baidu
map
Baidu
map
Baidu
map